Bupivacaine HCl Injection
cGMP deviations: Temperature abuse
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,535 recalls, newest first.
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
cGMP deviations: Temperature abuse
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
CGMP deviations: tablets cracking
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.